DUKE Robotics CEO granted 16,000 stock options

DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share.

Accepted by SEC EDGAR 03/12/2026 - 04:10 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.

Insider Trade Summary

Grant/Award: 16,000 shares

Grant/Award 1 txn

Insider Balucka Yossef

Role CHIEF EXECUTIVE OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	16,000	$0.00	$0.00

Holdings After Transaction: Option to Purchase Common Stock — 16,000 contracts (Direct)

Holdings Before and After: Option to Purchase Common Stock, 0 to 16,000 contracts (Direct)

Footnotes (1)

1. F1. The option vests in three equal annual installments beginning on March 10, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DUKE Robotics (DUKR) report for Balucka Yossef?

DUKE Robotics reported that CEO Balucka Yossef received a grant of options to purchase 16,000 shares of common stock. These options were awarded at an exercise price of $7.88 per share as part of his compensation package.

What are the key terms of Balucka Yossef’s stock options at DUKE Robotics (DUKR)?

The CEO was granted options on 16,000 shares of DUKE Robotics common stock at an exercise price of $7.88 per share. The options expire on March 10, 2032, providing a long-dated incentive aligned with potential future share performance.

How do the DUKE Robotics (DUKR) options granted to the CEO vest over time?

The 16,000 stock options granted to CEO Balucka Yossef vest in three equal annual installments. Vesting begins on March 10, 2027, so one-third of the options becomes exercisable each year over a three-year period.

Did DUKE Robotics (DUKR) CEO buy or sell any shares in this Form 4 filing?

The Form 4 shows an acquisition of derivative securities through an option grant, not an open-market buy or sell. CEO Balucka Yossef received 16,000 stock options as a compensation award, with no reported share sales or purchases.

What is Balucka Yossef’s option position in DUKE Robotics (DUKR) after this grant?

After the reported transaction, CEO Balucka Yossef holds 16,000 options to purchase DUKE Robotics common stock directly. This position reflects the full amount of the new grant, as indicated by the total derivative securities following the transaction.

When do the DUKE Robotics (DUKR) CEO’s new options expire?

The options granted to CEO Balucka Yossef expire on March 10, 2032. He can exercise vested options at an exercise price of $7.88 per share any time before this expiration date, subject to applicable company and regulatory rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Balucka Yossef

(Last) (First) (Middle)

C/O DUKE ROBOTICS CORP.

10 HARIMON STREET

(Street)

MEVO CARMEL SCIENCE & IND PARK L3 2069203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUKE Robotics Corp. [ DUKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$7.88	03/10/2026		A		16,000(1)		(1)	03/10/2032	Common Stock	16,000	$0	16,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on March 10, 2027.

	/s/ Yossef Balucka	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.